Artificial intelligence in cardiovascular prevention : new ways will open new doors
Copyright © 2022 Italian Federation of Cardiology - I.F.C. All rights reserved..
Prevention and effective treatment of cardiovascular disease are progressive issues that grow in tandem with the average age of the world population. Over recent decades, the potential role of artificial intelligence in cardiovascular medicine has been increasingly recognized because of the incredible amount of real-world data (RWD) regarding patient health status and healthcare delivery that can be collated from a variety of sources wherein patient information is routinely collected, including patient registries, clinical case reports, reimbursement claims and billing reports, medical devices, and electronic health records. Like any other (health) data, RWD can be analysed in accordance with high-quality research methods, and its analysis can deliver valuable patient-centric insights complementing the information obtained from conventional clinical trials. Artificial intelligence application on RWD has the potential to detect a patient's health trajectory leading to personalized medicine and tailored treatment. This article reviews the benefits of artificial intelligence in cardiovascular prevention and management, focusing on diagnostic and therapeutic improvements without neglecting the limitations of this new scientific approach.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Journal of cardiovascular medicine (Hagerstown, Md.) - 24(2023), Suppl 2 vom: 01. Mai, Seite e106-e115 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ciccarelli, Michele [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 17.05.2023 Date Revised 17.08.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2459/JCM.0000000000001431 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356892379 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356892379 | ||
003 | DE-627 | ||
005 | 20231226071426.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2459/JCM.0000000000001431 |2 doi | |
028 | 5 | 2 | |a pubmed24n1189.xml |
035 | |a (DE-627)NLM356892379 | ||
035 | |a (NLM)37186561 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ciccarelli, Michele |e verfasserin |4 aut | |
245 | 1 | 0 | |a Artificial intelligence in cardiovascular prevention |b new ways will open new doors |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.05.2023 | ||
500 | |a Date Revised 17.08.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Italian Federation of Cardiology - I.F.C. All rights reserved. | ||
520 | |a Prevention and effective treatment of cardiovascular disease are progressive issues that grow in tandem with the average age of the world population. Over recent decades, the potential role of artificial intelligence in cardiovascular medicine has been increasingly recognized because of the incredible amount of real-world data (RWD) regarding patient health status and healthcare delivery that can be collated from a variety of sources wherein patient information is routinely collected, including patient registries, clinical case reports, reimbursement claims and billing reports, medical devices, and electronic health records. Like any other (health) data, RWD can be analysed in accordance with high-quality research methods, and its analysis can deliver valuable patient-centric insights complementing the information obtained from conventional clinical trials. Artificial intelligence application on RWD has the potential to detect a patient's health trajectory leading to personalized medicine and tailored treatment. This article reviews the benefits of artificial intelligence in cardiovascular prevention and management, focusing on diagnostic and therapeutic improvements without neglecting the limitations of this new scientific approach | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Cardiovascular Agents |2 NLM | |
700 | 1 | |a Giallauria, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Carrizzo, Albino |e verfasserin |4 aut | |
700 | 1 | |a Visco, Valeria |e verfasserin |4 aut | |
700 | 1 | |a Silverio, Angelo |e verfasserin |4 aut | |
700 | 1 | |a Cesaro, Arturo |e verfasserin |4 aut | |
700 | 1 | |a Calabrò, Paolo |e verfasserin |4 aut | |
700 | 1 | |a De Luca, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Mancusi, Costantino |e verfasserin |4 aut | |
700 | 1 | |a Masarone, Daniele |e verfasserin |4 aut | |
700 | 1 | |a Pacileo, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Tourkmani, Nidal |e verfasserin |4 aut | |
700 | 1 | |a Vigorito, Carlo |e verfasserin |4 aut | |
700 | 1 | |a Vecchione, Carmine |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of cardiovascular medicine (Hagerstown, Md.) |d 2006 |g 24(2023), Suppl 2 vom: 01. Mai, Seite e106-e115 |w (DE-627)NLM162293844 |x 1558-2035 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:Suppl 2 |g day:01 |g month:05 |g pages:e106-e115 |
856 | 4 | 0 | |u http://dx.doi.org/10.2459/JCM.0000000000001431 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e Suppl 2 |b 01 |c 05 |h e106-e115 |